TG Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
19.04.24
/
50%
€12.95
Target price
19.04.25
€23.48
Performance (%)
50.12%
Price
07.10.24
€19.44
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for TG Therapeutics Inc. has seen massive gains of 50.12%. This prediction currently runs until 19.04.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
TG Therapeutics Inc. | -7.473% | -7.473% |
iShares Core DAX® | -1.958% | 4.037% |
iShares Nasdaq 100 | 0.272% | 8.670% |
iShares Nikkei 225® | 0.377% | 7.232% |
iShares S&P 500 | 0.370% | 6.511% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $25.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for TG Therapeutics Inc.
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.50
01.11.23
01.11.23
€21.76
01.11.24
01.11.24
104.67%
07.10.24
07.10.24
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.89
07.08.23
07.08.23
€19.99
07.08.24
07.08.24
106.21%
08.08.24
08.08.24